Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.
Park YS, Kim J, Ryu YS, Moon JH, Shin YJ, Kim JH, Hong SW, Jung SA, Lee S, Kim SM, Lee DH, Kim DY, Yun H, You JE, Yoon DI, Kim CH, Koh DI, Jin DH.
Park YS, et al. Among authors: lee dh, lee s.
Cancer Biol Ther. 2023 Dec 31;24(1):2246208. doi: 10.1080/15384047.2023.2246208.
Cancer Biol Ther. 2023.
PMID: 37621144
Free PMC article.